Search

Your search keyword '"Diabetic Neuropathies etiology"' showing total 57 results
Start Over Descriptor "Diabetic Neuropathies etiology" Publisher nippon rinsho co
57 results on '"Diabetic Neuropathies etiology"'

1. [Pathogenesis of diabetic neuropathy].

Author

Sanada M, Matsui M, and Yasuda H

Subjects
Animals, Cytokines immunology, Diabetic Neuropathies physiopathology, Genetic Predisposition to Disease, Glycation End Products, Advanced blood, Humans, Protein Kinase C metabolism, Stress, Physiological, Diabetic Neuropathies etiology
Published
2016

2. [Diabetic neuopathy].

Author

Yasuda H

Subjects
Accidental Falls, Activities of Daily Living, Acute Disease, Aged, Aged, 80 and over, Chronic Disease, Chronic Pain etiology, Diabetic Foot etiology, Early Diagnosis, Humans, Hyperglycemia complications, Hypertension complications, Hypoglycemia chemically induced, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents adverse effects, Metabolic Syndrome complications, Risk Factors, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Diabetic Neuropathies prevention & control, Diabetic Neuropathies therapy
Abstract

In view of increasing number of elderly diabetic patients and their westernized lifestyle, diabetic foot and fractures due to fall attributable to diabetic neuropathy may be common diseases which disturb patients' QOL. Since any therapeutic drugs for patients with diabetic neuropathy have not been fully accepted, much attention should be paid to intensification of self-care for foot lesion and exercise and balance training through education. Some of them may show orthostatic hypotension, gastroparesis, etc. Others may complain of pain in limbs. Taken together, management for elderly diabetic patients may well be achieved through education and with symptomatic therapy.

Published
2013

3. [Hypertension and abnormal lipid metabolism].

Author

Nishimura H

Subjects
Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Diabetic Retinopathy etiology, Humans, Diabetic Angiopathies etiology, Hypertension complications, Lipid Metabolism Disorders complications
Published
2012

4. [Pathogenesis of diabetic neuropathy].

Author

Yasuda H

Subjects
Diabetic Neuropathies metabolism, Humans, Inflammation metabolism, Oxidative Stress, Peripheral Nerves metabolism, Polymers metabolism, Receptor for Advanced Glycation End Products, Receptors, Immunologic metabolism, Diabetic Neuropathies etiology
Published
2012

6. [Diabetic neuropathy].

Author

Yagihashi S

Subjects
Aldehyde Reductase antagonists & inhibitors, Central Nervous System Agents therapeutic use, Cytokines, Enzyme Inhibitors therapeutic use, Glycation End Products, Advanced metabolism, Humans, Hyperglycemia complications, Hypoglycemic Agents therapeutic use, Nerve Fibers pathology, Oxidative Stress, Peripheral Nerves pathology, Polymers metabolism, Prognosis, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Diabetic Neuropathies pathology, Diabetic Neuropathies therapy
Published
2006

8. [Concept and epidemiology of diabetic neuropathies].

Author

Matsuoka K

Subjects
Disease Progression, Humans, Prevalence, Severity of Illness Index, Diabetic Neuropathies classification, Diabetic Neuropathies diagnosis, Diabetic Neuropathies epidemiology, Diabetic Neuropathies etiology
Published
2005

9. [Early diagnosis of peripheral neuropathy in patients with impaired glucose tolerance (IGT)].

Author

Yagihashi S

Subjects
Diabetic Neuropathies pathology, Diabetic Neuropathies physiopathology, Glucose Intolerance physiopathology, Glycation End Products, Advanced metabolism, Humans, Hyperglycemia complications, Hyperglycemia metabolism, Insulin Resistance, Microcirculation pathology, Oxidative Stress, Peripheral Nerves blood supply, Peripheral Nerves pathology, Polymers metabolism, Postprandial Period, Sorbitol metabolism, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Glucose Intolerance complications
Published
2005

10. [Role of Ca2+ channels in the pathogenesis of diabetic neuropathy].

Author

Sanada M and Yasuda H

Subjects
Animals, Calcium physiology, Calcium Channel Blockers therapeutic use, Calcium Channels classification, Calcium Signaling, Diabetic Neuropathies drug therapy, Humans, Ion Channels physiopathology, Peripheral Nervous System metabolism, Sodium-Potassium-Exchanging ATPase physiology, Calcium Channels physiology, Diabetic Neuropathies etiology
Published
2005

11. [Metabolic factors in the pathogenesis of diabetic neuropathies].

Author

Hamada Y

Subjects
Aldehyde Reductase genetics, Diabetic Neuropathies metabolism, Genetic Predisposition to Disease genetics, Glucose metabolism, Glycation End Products, Advanced metabolism, Humans, Oxidative Stress, Polymorphism, Genetic, Protein Kinase C metabolism, Protein Kinase C beta, Sorbitol metabolism, Diabetic Neuropathies etiology, Polymers metabolism
Published
2005

12. [Pathogenesis and progression of neuropathies in diabetic patients with endothelial dysfunction].

Author

Naruse K and Nakamura J

Subjects
Aldehyde Reductase antagonists & inhibitors, Animals, Antioxidants therapeutic use, C-Peptide therapeutic use, Diabetic Neuropathies drug therapy, Disease Progression, Drug Design, Endothelium, Vascular cytology, Humans, Nitric Oxide metabolism, Nitric Oxide Synthase physiology, Nitric Oxide Synthase Type III, Peripheral Nerves blood supply, Protein Kinase C antagonists & inhibitors, Protein Kinase C physiology, Protein Kinase C beta, Thioctic Acid therapeutic use, Vasodilation, Diabetes Mellitus physiopathology, Diabetic Neuropathies etiology, Endothelium, Vascular physiopathology
Published
2005

13. [Symptomatic treatment of painful diabetic neuropathy].

Author

Maeda K and Yasuda H

Subjects
Antitussive Agents therapeutic use, Dextromethorphan therapeutic use, Diabetic Neuropathies etiology, Fructose analogs & derivatives, Fructose therapeutic use, Gabapentin, Ganglia, Spinal physiology, Humans, Lamotrigine, Nerve Fibers physiology, Posterior Horn Cells physiology, Pregabalin, Sodium Channels physiology, Topiramate, Triazines therapeutic use, gamma-Aminobutyric Acid analogs & derivatives, Amines therapeutic use, Anti-Asthmatic Agents therapeutic use, Anticonvulsants therapeutic use, Antidepressive Agents therapeutic use, Cyclohexanecarboxylic Acids therapeutic use, Diabetic Neuropathies therapy, Mexiletine therapeutic use, Selective Serotonin Reuptake Inhibitors therapeutic use, gamma-Aminobutyric Acid therapeutic use
Published
2005

14. [Recommendation of smoking cessation for diabetic patients].

Author

Tsuda K

Subjects
Arteriosclerosis etiology, Arteriosclerosis prevention & control, Counseling, Diabetic Nephropathies prevention & control, Diabetic Neuropathies etiology, Diabetic Neuropathies prevention & control, Diabetic Retinopathy etiology, Diabetic Retinopathy prevention & control, Humans, Insulin metabolism, Insulin Resistance, Insulin Secretion, Myocardial Infarction etiology, Myocardial Infarction prevention & control, Nicotine administration & dosage, Physician's Role, Risk Factors, Smoking epidemiology, Stroke etiology, Stroke prevention & control, Diabetes Mellitus, Type 2 etiology, Diabetic Nephropathies etiology, Smoking adverse effects, Smoking Cessation methods
Published
2005

15. [Nerve flow dynamics in the pathogenesis of diabetic neuropathy].

Author

Ueda H

Subjects
Aldehyde Reductase antagonists & inhibitors, Animals, Capillaries physiopathology, Capillary Permeability, Diabetic Neuropathies therapy, Enzyme Inhibitors therapeutic use, Genetic Therapy, Hepatocyte Growth Factor genetics, Humans, Ischemia, Oxidative Stress, Regional Blood Flow, Reperfusion Injury etiology, Rhodanine analogs & derivatives, Rhodanine therapeutic use, Thiazolidines, Vascular Endothelial Growth Factor A genetics, Diabetic Neuropathies etiology, Peripheral Nerves blood supply
Published
2005

16. [Pupillary dysfunctions in diabetic patients].

Author

Kitano S

Subjects
Diabetes Mellitus drug therapy, Diabetic Neuropathies diagnosis, Diabetic Neuropathies therapy, Diagnosis, Differential, Diagnostic Techniques, Ophthalmological, Humans, Hypoglycemic Agents administration & dosage, Oculomotor Nerve Diseases diagnosis, Oculomotor Nerve Diseases etiology, Oculomotor Nerve Diseases therapy, Pupil physiology, Pupil Disorders diagnosis, Pupil Disorders therapy, Diabetic Neuropathies etiology, Pupil Disorders etiology
Published
2005

17. [Role of cytokine in diabetic neuropathy].

Author

Yagihashi S and Wada R

Subjects
Animals, Brain-Derived Neurotrophic Factor physiology, Diabetic Neuropathies drug therapy, Drug Design, Glycation End Products, Advanced metabolism, Humans, Interleukins physiology, Nerve Growth Factor physiology, Oxidative Stress, Polymers metabolism, Somatomedins physiology, Tumor Necrosis Factor-alpha physiology, Cytokines physiology, Diabetic Neuropathies etiology
Published
2005

18. [Pathophysiological aspects of diabetic polyneuropathy].

Author

Baba M

Subjects
Axons pathology, Central Nervous System pathology, Central Nervous System physiopathology, Demyelinating Diseases pathology, Diabetic Neuropathies diagnosis, Diabetic Neuropathies pathology, Diabetic Neuropathies physiopathology, Humans, Motor Neurons physiology, Neural Conduction, Neurons, Afferent physiology, Peripheral Nerves pathology, Reference Standards, Severity of Illness Index, Diabetic Neuropathies etiology
Published
2005

19. [Diabetic amyotrophy].

Author

Kimura M

Subjects
Acute Disease, Diabetic Neuropathies diagnosis, Diabetic Neuropathies physiopathology, Diabetic Neuropathies therapy, Electromyography, Humans, Hypoglycemic Agents administration & dosage, Immune System Diseases complications, Immunoglobulins, Intravenous, Ischemia complications, Magnetic Resonance Imaging, Microcirculation, Neural Conduction, Prognosis, Tomography, X-Ray Computed, Vasculitis complications, Diabetes Mellitus, Type 2 complications, Diabetic Neuropathies etiology
Published
2005

20. [Cytokines and microangiopathy].

Author

Kawakami M and Tamemoto H

Subjects
Animals, Ciliary Neurotrophic Factor physiology, Endothelins physiology, Eye Proteins physiology, Humans, Intercellular Adhesion Molecule-1 physiology, Nerve Growth Factors physiology, Osteopontin, Protein Kinase C physiology, Serpins physiology, Sialoglycoproteins physiology, Angiopoietins physiology, Angiostatins physiology, Antigens, Surface physiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Diabetic Retinopathy etiology, Proteins physiology, Vascular Endothelial Growth Factor A physiology
Published
2005

21. [Development of therapeutic agents for diabetic neuropathies].

Author

Nakamura J

Subjects
Aldehyde Reductase antagonists & inhibitors, C-Peptide therapeutic use, Genetic Therapy, Glycation End Products, Advanced, Hedgehog Proteins, Humans, Nerve Growth Factor therapeutic use, Oxidative Stress, Polymers metabolism, Protein Kinase C antagonists & inhibitors, Protein Kinase C metabolism, Rhodanine therapeutic use, Thiadiazoles therapeutic use, Thiamine analogs & derivatives, Thiamine therapeutic use, Thiazoles therapeutic use, Thiazolidines, Trans-Activators therapeutic use, Vascular Endothelial Growth Factor A genetics, Antioxidants therapeutic use, Diabetic Neuropathies etiology, Diabetic Neuropathies therapy, Drug Design, Enzyme Inhibitors therapeutic use, Indoles therapeutic use, Maleimides therapeutic use, Rhodanine analogs & derivatives
Published
2005

22. [Diabetic neuropathy].

Author

Hotta N

Subjects
Humans, Risk Factors, Diabetic Neuropathies diagnosis, Diabetic Neuropathies epidemiology, Diabetic Neuropathies etiology, Diabetic Neuropathies physiopathology
Published
2005

23. [Inositol].

Author

Nakashima S

Subjects
Animals, Atrophy diagnosis, Biomarkers analysis, Brain pathology, Chromatography, Gas, Diabetic Neuropathies etiology, Gas Chromatography-Mass Spectrometry, Humans, Inositol physiology, Meningitis diagnosis, Reference Values, Sepsis diagnosis, Diabetic Neuropathies diagnosis, Inositol analysis, Kidney Failure, Chronic diagnosis
Published
2004

24. [Hypertension in patients with diabetes mellitus].

Author

Okubo K and Kiyohara Y

Subjects
Diabetic Nephropathies epidemiology, Diabetic Nephropathies etiology, Diabetic Neuropathies epidemiology, Diabetic Neuropathies etiology, Diabetic Retinopathy epidemiology, Diabetic Retinopathy etiology, Humans, Hypertension drug therapy, Myocardial Ischemia epidemiology, Myocardial Ischemia etiology, Risk, Stroke epidemiology, Stroke etiology, Diabetes Complications, Hypertension complications
Abstract

It is well known that diabetes often induces macrovascular and microvascular complications, and hypertension is also considered to be an important risk factor for macrovascular events. Recent epidemiological studies have proved the possibility that hypertension among patients with diabetes greatly increases the risks of these complications. However, the impact of hypertension on stroke and microvascular complications is considered to be greater than that on coronary heart disease. Co-existent metabolic risk factors such as hyperlipidemia rather than hypertension may affect more coronary heart disease. Antihypertensive treatment among diabetic patients is expected to reduce various complications, but management of metabolic risk factors is also needed to prevent coronary heart disease.

Published
2003

25. [Early detection of diabetic neuropathy].

Author

Suzuki Y

Subjects
Aldehyde Reductase physiology, Chronic Disease, Diabetic Neuropathies classification, Diabetic Neuropathies etiology, Evidence-Based Medicine, Glycation End Products, Advanced metabolism, Humans, Oxidative Stress physiology, Protein Kinase C metabolism, Reference Standards, Sorbitol metabolism, Diabetic Neuropathies diagnosis
Published
2002

26. [Risk factors and onset mechanisms of diabetic neuropathy].

Author

Hamada Y

Subjects
Aldehyde Reductase genetics, Aldehyde Reductase physiology, Animals, Blood Glucose metabolism, Capillary Permeability, Genetic Predisposition to Disease, Glycation End Products, Advanced metabolism, Growth Substances physiology, Humans, Hypertension complications, Oxidative Stress physiology, Protein Kinase C metabolism, Risk Factors, Smoking adverse effects, Sorbitol metabolism, Diabetic Neuropathies etiology
Published
2002

27. [Environmental factors as the risk factors for diabetic complications].

Author

Hashimoto N and Saito Y

Subjects
Body Weight, Humans, Hyperglycemia complications, Hyperlipidemias complications, Risk Factors, Diabetic Angiopathies etiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Hypertension complications, Obesity complications
Published
2002

28. [Risk factors for diabetic complications: Abnormality of polyol metabolism].

Author

Hotta N

Subjects
Aldehyde Reductase genetics, Animals, Fructose metabolism, Glucose metabolism, Humans, Polymorphism, Genetic, Risk Factors, Aldehyde Reductase physiology, Diabetic Angiopathies etiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Sorbitol metabolism
Published
2002

29. [Prevention and treatment of diabetic neuropathy].

Author

Uesaka Y

Subjects
Aldehyde Reductase antagonists & inhibitors, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Antioxidants therapeutic use, Chronic Disease, Diabetic Neuropathies etiology, Enzyme Inhibitors therapeutic use, Glycation End Products, Advanced antagonists & inhibitors, Guanidines therapeutic use, Humans, Insulin administration & dosage, Oxidative Stress, Rhodanine therapeutic use, Thiazolidines, gamma-Linolenic Acid therapeutic use, Diabetic Neuropathies prevention & control, Diabetic Neuropathies therapy, Rhodanine analogs & derivatives
Published
2002

30. [Role of PKC in the pathogenesis of diabetic vascular complications].

Author

Inoguchi T and Umeda F

Subjects
Animals, Clinical Trials as Topic, Diabetic Nephropathies drug therapy, Diabetic Neuropathies drug therapy, Diabetic Retinopathy drug therapy, Enzyme Inhibitors therapeutic use, Humans, Indoles therapeutic use, Isoenzymes antagonists & inhibitors, Isoenzymes metabolism, Isoenzymes physiology, Maleimides therapeutic use, Protein Kinase C antagonists & inhibitors, Protein Kinase C metabolism, Protein Kinase C beta, Risk Factors, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Diabetic Retinopathy etiology, Protein Kinase C physiology
Published
2002

31. [Diabetic orthostatic hypotension].

Author

Goda K, Sasaki E, and Takamatsu J

Subjects
Cardiovascular Agents therapeutic use, Chronic Disease, Diagnosis, Differential, Humans, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Diabetic Neuropathies therapy, Hypotension, Orthostatic diagnosis, Hypotension, Orthostatic etiology, Hypotension, Orthostatic therapy
Published
2002

32. [Pupillary dysfunction in diabetes mellitus].

Author

Nakamura J and Nakayama M

Subjects
Autonomic Pathways physiopathology, Chronic Disease, Diabetic Neuropathies etiology, Diabetic Neuropathies physiopathology, Humans, Diabetic Neuropathies diagnosis, Neurologic Examination methods, Pupil physiology
Published
2002

33. [Diabetic amyotrophy].

Author

Ueyama H and Kumamoto T

Subjects
Chronic Disease, Diagnosis, Differential, Female, Humans, Middle Aged, Muscle, Skeletal pathology, Neural Conduction, Peripheral Nerves pathology, Peripheral Nerves physiopathology, Prognosis, gamma-Globulins administration & dosage, Diabetic Neuropathies etiology, Diabetic Neuropathies physiopathology, Diabetic Neuropathies therapy, Muscular Atrophy etiology, Muscular Atrophy physiopathology, Muscular Atrophy therapy
Published
2002

34. [Risk factors for diabetic complications: Oxidative stress].

Author

Osawa T

Subjects
Animals, Antioxidants therapeutic use, Diabetic Angiopathies prevention & control, Diabetic Nephropathies prevention & control, Diabetic Neuropathies prevention & control, Free Radicals metabolism, Free Radicals toxicity, Humans, Reactive Oxygen Species metabolism, Reactive Oxygen Species toxicity, Risk Factors, Diabetic Angiopathies etiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Oxidative Stress
Published
2002

35. [The study of development and progression of long-term complications in type I diabetes].

Author

Araki E and Matsumura T

Subjects
Blood Glucose, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 complications, Diabetic Angiopathies etiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Disease Progression, Glycated Hemoglobin metabolism, Humans, Quality of Life, Time Factors, Clinical Trials as Topic, Diabetes Mellitus, Type 1 drug therapy, Diabetic Angiopathies prevention & control, Diabetic Nephropathies prevention & control, Diabetic Neuropathies prevention & control, Hypoglycemic Agents administration & dosage, Insulin administration & dosage
Published
2002

36. [Erythropoietin-depletion induced anemia in early or advanced diabetic nephropathy].

Author

Inomata S

Subjects
Anemia drug therapy, Angiotensin II, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Animals, Autonomic Nervous System Diseases etiology, Diabetic Nephropathies drug therapy, Diabetic Neuropathies etiology, Erythropoietin metabolism, Erythropoietin therapeutic use, Humans, Recombinant Proteins, Anemia etiology, Diabetic Nephropathies etiology, Erythropoietin deficiency
Published
2002

37. [Myo-inositol].

Author

Nakashima E and Nakamura J

Subjects
Biomarkers blood, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Diabetic Neuropathies metabolism, Heat-Shock Proteins metabolism, Humans, Inositol physiology, Phosphatidylinositols metabolism, Sodium-Potassium-Exchanging ATPase metabolism, Symporters metabolism, Inositol blood, Membrane Proteins
Published
2002

39. [Superoxide dismutase (SOD)].

Author

Ishigami M

Subjects
Biomarkers blood, Diabetic Angiopathies diagnosis, Diabetic Angiopathies etiology, Diabetic Nephropathies diagnosis, Diabetic Nephropathies etiology, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Free Radicals metabolism, Humans, Oxidative Stress physiology, Superoxides metabolism, Superoxide Dismutase blood, Superoxide Dismutase physiology
Published
2002

40. [Abnormal inositol phospholipid metabolism in diabetes].

Author

Hashimoto T

Subjects
Animals, Diabetes Mellitus blood, Diabetic Neuropathies etiology, Diabetic Neuropathies metabolism, Humans, Insulin metabolism, Insulin Resistance, Insulin Secretion, Islets of Langerhans metabolism, Platelet Activation, Diabetes Mellitus metabolism, Phosphatidylinositols metabolism
Published
2002

41. [Soluble VCAM-1].

Author

Yoshizawa M, Takamura T, and Kobayashi K

Subjects
Biomarkers blood, Diabetes Mellitus metabolism, Diabetic Angiopathies diagnosis, Diabetic Angiopathies etiology, Diabetic Nephropathies diagnosis, Diabetic Nephropathies etiology, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Endothelium, Vascular metabolism, Epoprostenol pharmacology, Epoprostenol therapeutic use, Fenofibrate pharmacology, Fenofibrate therapeutic use, Humans, NF-kappa B physiology, Solubility, Vascular Cell Adhesion Molecule-1 blood
Published
2002

42. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment].

Author

Maeda K and Yasuda H

Subjects
Animals, Diabetic Neuropathies drug therapy, Humans, Nerve Growth Factors physiology, Oxidative Stress, Diabetic Neuropathies etiology
Abstract

Diabetic symmetrical polyneuropathy have been known to arise from metabolic alteration such as accelerated polyol pathway and/or from neurovascular deficit. Recently, two other hypotheses were confirmed. Decreased neurotrophic supports were reported in diabetic neuropathy. Subcutaneous injection of recombinant human nerve growth factor ameliorated sensory symptoms and cooling detection threshold. The most common adverse effect was injection site hyperalagesia. Brain-derived neurotrophic factor, neurotrophin-3 and insulin-like growth factors are under clinical trials. The excessive oxidative stresses are also associated with diabetic neuropathy. Increased production and decreased scavenge system of free radicals enhance their cytotoxic effects. Alpha-lipoic acid, gliclazide and troglitazone have been reported to be effective for diabetic neuropathy.

Published
1999

44. [Metabolic disorder of polyol pathway].

Author

Hotta N

Subjects
Diabetic Neuropathies etiology, Humans, NAD metabolism, NADP metabolism, Diabetes Mellitus metabolism, Fructose metabolism, Glucose metabolism, Sorbitol metabolism
Published
1997

45. [Statistic survey of diabetes, insipidus, nephrogenic diabetes insipidus in Japan].

Author

Nishimura M and Yoshida S

Subjects
Adolescent, Age Factors, Brain Neoplasms complications, Child, Preschool, Deamino Arginine Vasopressin adverse effects, Deamino Arginine Vasopressin therapeutic use, Diabetes Insipidus diagnosis, Diabetes Insipidus etiology, Diabetic Nephropathies diagnosis, Diabetic Nephropathies etiology, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Female, Humans, Infant, Japan epidemiology, Male, Reference Standards, Sex Factors, Diabetes Insipidus epidemiology, Diabetic Nephropathies epidemiology, Diabetic Neuropathies epidemiology
Published
1993

46. [Diabetic neuropathy--a review of pathological studies].

Author

Kito S and Yamamura Y

Subjects
Adolescent, Adult, Aged, Animals, Diabetes Mellitus, Experimental pathology, Diabetic Neuropathies etiology, Diabetic Neuropathies metabolism, Disease Models, Animal, Humans, Inositol metabolism, Middle Aged, Peripheral Nerves pathology, Rats, Sodium-Potassium-Exchanging ATPase deficiency, Sorbitol metabolism, Diabetic Neuropathies pathology
Published
1991

47. [Diabetic microangiopathy--definition and classification].

Author

Yokose T and Isogai Y

Subjects
Basement Membrane pathology, Blood Coagulation, Blood Viscosity, Capillaries pathology, Diabetic Angiopathies pathology, Diabetic Angiopathies physiopathology, Diabetic Nephropathies etiology, Diabetic Nephropathies pathology, Diabetic Neuropathies etiology, Diabetic Neuropathies pathology, Diabetic Retinopathy etiology, Diabetic Retinopathy pathology, Humans, Muscles blood supply, Oxygen metabolism, Polymers metabolism, Skin blood supply, Diabetic Angiopathies classification
Published
1991

48. [Diabetic neuropathy--pathogenesis and precipitating factors].

Author

Wasada T

Subjects
Alcohol Drinking adverse effects, Animals, Diabetic Neuropathies drug therapy, Diabetic Neuropathies metabolism, Fructose metabolism, Glucose metabolism, Humans, Imidazoles therapeutic use, Inositol metabolism, Risk Factors, Smoking adverse effects, Sodium-Potassium-Exchanging ATPase metabolism, Sorbitol metabolism, Diabetic Neuropathies etiology, Energy Metabolism, Imidazolidines
Published
1991

49. [Diabetic complication: definition and classification].

Author

Nishizawa Y

Subjects
Diabetes Mellitus classification, Diabetes Mellitus, Type 1 complications, Diabetes Mellitus, Type 2 complications, Diabetic Angiopathies classification, Diabetic Angiopathies etiology, Diabetic Coma etiology, Diabetic Nephropathies etiology, Diabetic Neuropathies etiology, Diabetic Retinopathy etiology, Humans, Diabetes Complications
Published
1991

50. [Diabetes and vitamin deficiency].

Author

Sakamoto N and Sato Y

Subjects
Animals, Humans, Vitamin B 12 Deficiency complications, Vitamin B 6 Deficiency complications, Vitamin D Deficiency complications, Vitamin E Deficiency complications, Avitaminosis complications, Diabetic Angiopathies etiology, Diabetic Neuropathies etiology
Published
1990

Catalog

Books, media, physical & digital resources
See catalog results